Search Results
Feb 02, 2026, 09:44 ET Teksański Instytut Arytmii Serca przy Centrum Medycznym St. David's jako pierwszy w USA wszczepia nową elektrodę defibrylacyjną zatwierdzoną przez FDA
elektrody defibrylacyjnej zatwierdzonej przez FDA - specjalistycznego, izolowanego przewodu, który łączy się z wszczepialnym kardiowerterem-defibrylatorem (ICD) lub urządzeniem do terapii resynchronizującej serce z funkcją defibrylacji (CRT-D) i koryguje zaburzenia rytmu serca. Jest to najmniejsza na świecie
More news about: Texas Cardiac Arrhythmia Institute at St. David’s Medical Center
Feb 02, 2026, 09:08 ET Texas Cardiac Arrhythmia Institute at St. David's Medical Center first in U.S. to implant FDA-approved novel defibrillation lead
nation to implant an FDA-approved novel defibrillation lead—a specialized, insulated wire that connects to an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRT-Ds) device to the heart and corrects abnormal rhythm. The defibrillation lead is the world's smallest, catheter-delivered
More news about: Texas Cardiac Arrhythmia Institute at St. David’s Medical Center
Feb 02, 2026, 07:08 ET Texas Cardiac Arrhythmia Institute at St. David's Medical Center primeiro nos EUA a implantar novo eletrodo de desfibrilação aprovado pela FDA
implantar um novo eletrodo de desfibrilação aprovado pela FDA - um fio isolado especializado que se conecta a um desfibrilador cardioversor implantável (ICD) ou dispositivo de terapia de ressincronização cardíaca (CRT-Ds) no coração e corrige o ritmo anormal. O eletrodo de desfibrilação é o menor eletrodo
More news about: Texas Cardiac Arrhythmia Institute at St. David’s Medical Center
Feb 02, 2026, 04:08 ET Texas Cardiac Arrhythmia Institute at St. David's Medical Center first in U.S. to implant FDA-approved novel defibrillation lead
nation to implant an FDA-approved novel defibrillation lead—a specialized, insulated wire that connects to an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRT-Ds) device to the heart and corrects abnormal rhythm. The defibrillation lead is the world's smallest, catheter-delivered
More news about: Texas Cardiac Arrhythmia Institute at St. David’s Medical Center
Feb 02, 2026, 03:08 ET Texaský inštitút srdcových arytmií v St. David's Medical Center ako prvý v USA implantuje novú defibrilačnú elektródu schválenú FDA
implantovali novú defibrilačnú elektródu schválenú FDA. Ide o špecializovaný izolovaný drôt, ktorý sa pripája k implantovateľnému kardioverteru-defibrilátoru (ICD) alebo zariadeniu na resynchronizačnú terapiu s defibrilátorom (CRT-D) so srdcom a koriguje abnormálny rytmus. Defibrilačná elektróda je najmenšia defibrilačná
More news about: Texas Cardiac Arrhythmia Institute at St. David’s Medical Center
Feb 02, 2026, 03:08 ET Texaský institut pro srdeční arytmii v St. David's Medical Center jako první v USA implantoval novou defibrilační elektrodu schválenou FDA
schválenou FDA (Úřadem pro kontrolu potravin a léčiv) – speciální izolovaný vodič, který se připojuje k implantabilnímu kardioverteru-defibrilátoru (ICD) nebo zařízení pro resynchronizační terapii srdce (CRT-D) a koriguje abnormální rytmus. Defibrilační elektroda je nejmenší defibrilační elektroda na
More news about: Texas Cardiac Arrhythmia Institute at St. David’s Medical Center
Feb 02, 2026, 03:08 ET Texas Cardiac Arrhythmia Institute am St. David's Medical Center implantiert als erstes in den USA die von der FDA zugelassene neuartige Defibrillationselektrode
zugelassene neuartige Defibrillationsleitung implantiert - ein spezieller, isolierter Draht, der mit einem implantierbaren Kardioverter-Defibrillator (ICD) oder einem Gerät für die kardiale Resynchronisationstherapie (CRT-Ds) am Herzen verbunden wird und den abnormalen Rhythmus korrigiert. Die Defibrillationselektrode
More news about: Texas Cardiac Arrhythmia Institute at St. David’s Medical Center
Feb 02, 2026, 03:08 ET Le Texas Cardiac Arrhythmia Institute du St. David's Medical Center est le premier aux États-Unis à implanter une nouvelle sonde de défibrillation approuvée par la FDA
implanter une nouvelle sonde de défibrillation approuvée par la FDA - un fil isolé spécialisé qui se connecte à un défibrillateur cardioverteur implantable (ICD) ou à un dispositif de thérapie de resynchronisation cardiaque (CRT-Ds) dans le cœur et corrige le rythme anormal. La sonde de défibrillation est la
More news about: Texas Cardiac Arrhythmia Institute at St. David’s Medical Center
Feb 02, 2026, 01:08 ET Техасский институт сердечной аритмии, расположенный в Медицинском центре Св. Дэвида, первым в США имплантировал одобренный FDA новый дефибрилляционный электрод
FDA новый дефибрилляционный электрод — специализированный изолированный провод, который подключается к имплантируемому кардиовертеру-дефибриллятору (ICD) или устройству сердечной ресинхронизирующей терапии (CRT-D) и корректирует ненормальный ритм. Данный дефибрилляционный электрод является самым маленьким
More news about: Texas Cardiac Arrhythmia Institute at St. David’s Medical Center
Feb 01, 2026, 22:38 ET Texas Cardiac Arrhythmia Institute at St. David's Medical Center first in U.S. to implant FDA-approved novel defibrillation lead
nation to implant an FDA-approved novel defibrillation lead—a specialized, insulated wire that connects to an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRT-Ds) device to the heart and corrects abnormal rhythm. The defibrillation lead is the world's smallest, catheter-delivered
More news about: Texas Cardiac Arrhythmia Institute at St. David’s Medical Center
Feb 01, 2026, 21:08 ET Pertama di AS, Texas Cardiac Arrhythmia Institute di St. David's Medical Center mengimplan elektroda Defibrilator Kardioverter Implan (ICD) baru yang disetujui oleh FDA.
mengimplan elektroda defibrilasi baru yang disetujui FDA, yakni kabel berinsulasi khusus yang terhubung ke perangkat Implantable Cardioverter Defibrillator (ICD) atau Cardiac Resynchronization Therapy (CRT-Ds) ke jantung dan memperbaiki irama yang tidak normal. Elektroda defibrilasi ini terkecil di dunia dan
More news about: Texas Cardiac Arrhythmia Institute at St. David’s Medical Center
Feb 01, 2026, 21:08 ET Viện Rối loạn Nhịp tim Texas tại Trung tâm Y tế St. David's là đơn vị đầu tiên tại Hoa Kỳ thực hiện cấy ghép dây dẫn khử rung tim mới được FDA phê duyệt
Hoa Kỳ thực hiện cấy ghép một dây dẫn khử rung tim mới được FDA phê duyệt—một dây dẫn chuyên dụng, cách điện, kết nối với máy khử rung tim cấy ghép (ICD) hoặc thiết bị điều trị tái đồng bộ tim (CRT-D) với tim và điều chỉnh nhịp tim bất thường. Đây là dây dẫn khử rung tim nhỏ nhất thế giới được đưa vào
More news about: Texas Cardiac Arrhythmia Institute at St. David’s Medical Center
Feb 01, 2026, 20:08 ET 德州聖大衛醫療中心心律失常研究所是美國首家植入獲美國食品及藥物管理局批准的新型除顫導線的機構
Center) 心律失常研究所 (Texas Cardiac Arrhythmia Institute，TCAI) 的心臟電生理專家，近日成為全美首批成功植入一款獲美國食品及藥物管理局 (FDA) 批准的新型除顫導線的醫療團隊。該除顫導線為一條具備絕緣設計的專用導線，可連接植入式心臟復律除顫器 (ICD) 或心臟再同步治療裝置 (CRT-D)，將電能傳導至心臟以矯正異常心律。 該除顫導線為全球體積最小、可經導管植入的除顫導線，實現精準傳送並於右心室定位。首宗手術於 1 月 7 日進行，由 TCAI 的臨床心臟電生理專家 Robert Canby 醫生及 Amin Al-Ahmad 醫生共同完成。
More news about: Texas Cardiac Arrhythmia Institute at St. David’s Medical Center
Jan 15, 2026, 08:00 ET Aultman Health System Scales Nabla's Ambient AI Through Oracle Cerner Integration
they did not see with other tools evaluated. Clinicians cited examples such as automatically structuring chronic disease documentation or embedding ICD 10 codes directly within the assessment and plan, demonstrating a level of personalization that made documentation faster and more reliable. The system
More news about: Nabla
Jan 14, 2026, 08:00 ET From Path to Progress: Journal of Independent Medicine Launches 2026 With Its Fifth Issue--Entering Year Two of Conflict-Free, Evidence-Based Science
research. Diagnostic Neutrality or Sociopolitical Conformity? The Depathologisation of Gender Dysphoria and Gender Incongruence in the DSM and ICD — Max Thompson; Andrew J. AmosArgues recent nosology changes reflect sociopolitical pressures more than empirical advances and calls
More news about: Independent Medical Alliance
Jan 13, 2026, 13:00 ET Former Drawbridge Health CEO Launches Manifold Health AI at JPM to Build the First Digital Health Index Twin for Chronic Disease
to a FICO credit score, that enables forward-looking health risk forecasting.For decades, healthcare risk modeling has been built on CPT and ICD codes optimized for reimbursement rather than clinical accuracy. As a result, most forecasting is backward-looking, reactive, and structurally misaligned
More news about: Manifold Health
Jan 12, 2026, 09:40 ET IMO Health wins 2025 Modern Healthcare Best in Business Awards for data analytics and revenue cycle management
specific diagnoses for nearly half of patients and automated most coding. Furthermore, the company's clinical AI outperforms the leading GPT by 67% in ICD-10-CM mapping accuracy, ensuring faster, more trustworthy findings across care delivery and research.The award in Revenue Cycle Management recognizes
More news about: Intelligent Medical Objects, Inc.
Dec 18, 2025, 09:00 ET Claroty and Mission IT Partner to Secure U.S. Critical Infrastructure, Accelerate Entrance into U.S. Intelligence Community
distribution system, and cleartext communications by PLCs on the network—that the agency was able to remediate to pass facility commissioning and achieve ICD 503 and UFGS-25 05 11 ("Cybersecurity for Facility-Related Control Systems") compliance.These successful deployments underscore the immediate
More news about: Claroty
Dec 10, 2025, 19:00 ET RIMAN、⽇本市場進出を前にグローバル展開をさらに加速
ビヨンプール）は、長年の研究と済州島にある世界初のビヨンプール・スマートファームでの栽培によって開発され、2025年に⽶国農務省（USDA）より20年間の植物品種保護（PVP）を取得しました。一般的なツボクサより葉が大きく、美容成分を多く含むこの品種は、こだわりのスキンケア処方に使用されています。この「Giant BYoungPool」は、RIMANのフラッグシップブランドである「ICD」のシグネチャー原料として使用されています。ICDは科学的根拠に基づく処方、革新的なテクスチャー、多様な認証（ISO適合、Lava BYoungPool Water（ラヴァ ビヨンプール ウォーター）のハラール認証など）により、北米・欧州市場で急速に存在感を高めています。RIMANグローバル最高営業責任者（CSO）Hwang
More news about: RIMAN Inc.
Dec 08, 2025, 07:30 ET Recordati Rare Diseases Showcases Real-World Evidence Studies That Advance Understanding of Castleman Disease (CD) at the American Society of Hematology (ASH) Annual Meeting
Databases from January 1, 2016, through June 30, 2024, to inform understanding of disease burden. Patients with iMCD and controls were identified using the ICD-10 code for Castleman disease and minor diagnostic criteria, and treatment criteria for iMCD. iMCD patients were matched 1:3 with controls who had no
More news about: Recordati
Dec 03, 2025, 03:30 ET RIMAN acelera el crecimiento en México con la introducción de ICD Beauty
La nueva línea ICD Beauty representa una fusión perfecta de cuidado de la piel y color, trayendo formulaciones innovadoras y respaldadas por la ciencia a la categoría de maquillaje.La línea incluye:ICD Beauty Sheer Glow BBICD Beauty Luminous Glow
More news about: RIMAN Inc.
Nov 12, 2025, 16:05 ET Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update
Registrational Continuous Renal Replacement Therapy) study. An ICD-10 procedural code, XY0YX37, has been issued for the extracorporeal introduction of nafamostat. The ICD-10 code is a specific/billable code that can be used to indicate a procedure. LTX-608 is a proprietary
More news about: Talphera, Inc.
Nov 12, 2025, 10:46 ET Healthcare Claims Management Market to Witness Significant Growth Driven by Digital Transformation in Healthcare Operations: Verified Market Research®
as HIPAA in the U.S. and GDPR in Europe enforce strict guidelines on data security and claims reporting. The adoption of ICD-10 coding and electronic health records (EHR) integration mandates are compelling providers to invest in advanced claims management solutions.
More news about: Verified Market Research
Nov 11, 2025, 09:00 ET DeepScribe's Oncology Momentum Accelerates: Ambient AI Set to Capture 3.1 Million Cancer Care Visits Annually
documentation: 16% increase in diagnoses per visit 22% increase in ICD-10 diagnosis code specificity 22% increase in comorbidities captured 45% increase in capture of
More news about: DeepScribe
Nov 05, 2025, 03:00 ET Il Brasile partecipa al più importante congresso mondiale sul lipedema a Roma
diagnosticato come obesità o stile di vita sedentario. Riconosciuto dall'Organizzazione Mondiale della Sanità dal 2019, ha ricevuto una propria classificazione ICD nel 2022.Per maggiori informazioni: @lipedemabrasil | @conhecalipedema Link al programma:
More news about: Instituto Lipedema Brasil